GyrA and/or ParC alterations of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis

J Infect Chemother. 2018 Mar;24(3):232-235. doi: 10.1016/j.jiac.2017.10.013. Epub 2017 Nov 11.

Abstract

Of 73 clinical strains of Haemophilus influenzae isolated from the urethra of men with urogenital infections, we enrolled 6 strains (8.2%) with levofloxacin (LVFX) minimum inhibitory concentrations (MICs) of ≥0.03 μg/ml in this study. All the strains were isolated from non-gonococcal urethritis (NGU). We amplified the quinolone resistance-determining region of the gyrA gene and the analogous region of the parC gene from bacterial DNAs by PCR and sequenced the PCR products. Two strains with a LVFX MIC of 0.03 μg/ml had an amino acid change of Asp88 to Gly in GyrA. One with a LVFX MIC of 0.06 μg/ml had a change of Asp88 to Tyr in GyrA. Two with respective LVFX MICs of 0.12 and 0.25 μg/ml had a change of Ser84 to Leu in GyrA. One with a LVFX MIC of 1 μg/ml had changes of Ser84 to Leu in GyrA and of Ser84 to Ile in ParC. Multilocus sequence typing showed two strains with a change of Asp88 to Gly in GyrA had the same sequence type, but the others had sequence types different from each other. Single amino acid changes in GyrA alone or single changes in both GyrA and ParC could contribute to decreased susceptibility to fluoroquinolones in H. influenzae isolates from NGU. Most of the isolates with GyrA and/or ParC alterations would be multiclonal. The prevalence of such isolates would be relatively low, and they would still be susceptible to fluoroquinolones commonly prescribed for treatment of NGU.

Keywords: Fluoroquinolone resistance; GyrA; Haemophilus influenzae; ParC; Urethritis.

MeSH terms

  • Adult
  • Amino Acids / genetics
  • Anti-Bacterial Agents / therapeutic use
  • DNA Gyrase / genetics*
  • DNA Topoisomerase IV / genetics*
  • Drug Resistance, Bacterial / genetics*
  • Fluoroquinolones / therapeutic use
  • Haemophilus Infections / drug therapy
  • Haemophilus Infections / microbiology
  • Haemophilus influenzae / drug effects
  • Haemophilus influenzae / genetics*
  • Haemophilus influenzae / isolation & purification*
  • Humans
  • Levofloxacin / therapeutic use
  • Male
  • Microbial Sensitivity Tests
  • Urethra / microbiology*
  • Urethritis / drug therapy
  • Urethritis / microbiology*
  • Young Adult

Substances

  • Amino Acids
  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Levofloxacin
  • DNA Topoisomerase IV
  • DNA Gyrase